Lakeview’s Dr. Tina Trudel will be speaking on Neurotoxicology and the risks of living in a chemical world, as the key note address for the October 22, 2013 Maine Brain Injury Conference. This presentation will examine the impact of neurotoxin exposure, with a focus on central nervous system damage and concomitant symptoms. Common occupational and environmental neurotoxins will be discussed, as well as the effects of low level long-term exposure. Neuropsychological evaluation and findings will be highlighted. Participants will learn about the global issue of neurotoxin exposure and potential damage including: peripheral nervous system; central nervous system; combined CNS/PNS; indirect structural damage; and indirect reactive effects. Key physical, cognitive and behavioral symptoms, as well as soft signs, of neurotoxin injury, in the contexts of acute versus low level long term exposure will be identified. Specific classes of neurotoxins (metals, solvents, etc.), and their occupational and environmental risks and symptom profiles will be reviewed, along with general treatment options for more common neurotoxin exposures.
Dr. Amanda Goza has been promoted to Clinical Director of Lakeview NeuroRehabilitation Center in Effingham, NH. Dr. Goza joined Lakeview last year, leading our Youth Program. She is a senior psychologist with significant experience in management, training, policy and systems. Dr. Goza received her doctorate in Clinical Psychology from the APA accredited program at Virginia Polytechnic Institute and State University (Virginia Tech), and completed her APA accredited internship and fellowship at Virginia Commonwealth University’s Medical College of Virginia Hospital’s Treatment Center for Children. She has served as a director of behavior therapy and program support, and as a staff psychologist, at programs in Abilene, TX, and was most recently Director of Psychology and Clinical Services Development for Northern Virginia Mental Health Institute before joining Lakeview.
For the first time in memory, a President of the United States is directly addressing the human brain and all of the disorders stemming from brain dysfunction. On April 2nd, President Obama launched the BRAIN Initiative, a national public-private initiative to map the human brain. This project combines federal funds and private sector dollars in the same way done to map the human genome. The Human Genome project was an amazing success, the fruits of which will be borne for decades to come. According to the White House, along with advancing science and health, the Human Genome project has provided an economic return of $141 for every dollar invested. Undoubtedly, the BRAIN Initiative will reap similar scientific, therapeutic and economic returns.
The goal of the BRAIN Initiative is to develop the knowledge necessary to create new treatments, preventions and cures for such disorders as brain injury, autism, epilepsy, schizophrenia and autism. The White House presentation indicates that the federal government will spend more than $100 million on the initiative through three agencies: 1) $50 million from the Defense Advanced Research Projects Agency to understand functions of the brain; 2) $40 million from the National Institutes of Health to develop new tools, training programs and other resources; and 3) $20 million from the National Science Foundation to support physical, biological, social and behavioral sciences research. Private sector contributions include: 1) $60 million annually from the Allen Institute for Brain Science to understand how brain activity leads to perception, decision marking and actions; 2) $30 million annually from the Howard Hughes Medical Institute to develop new imaging technologies, and understand how information is stored and processed in neural networks; 3) $4 million annually for 10 years from the Kavli Foundation to address debilitating diseases and conditions; and 4) $28 million from the Salk Institute for Biological Studies to produce a sophisticated understanding of the brain from individual genes to neuronal circuits to behavior. A bioethical study commission will also be charged with examining the implications of brain mapping and advances in neuroscience in terms of social, legal and ethical implications.
Details about the Brain Initiative can be found at http://www.nih.gov/science/brain/index.htm, and the fact sheet from the White House Press Office at http://www.whitehouse.gov/the-press-office/2013/04/02/fact-sheet-brain-initiative.
Lakeview is pleased to congratulate Theresa Stevens, RN, MS, CRRN, CIC who has been recently elected to the Board of Directors for the South East Wisconsin Chapter of Association for Professionals in Infection Control and Epidemiology (APIC). Theresa’s appointment to the APIC Chapter Board of Directors is a great acknowledgment that helps showcase Theresa’s passion for improving patient care. Theresa serves as the Wisconsin facility’s Certified Infection Preventionist and continues to help guide our facility through improving our infection prevention and infection control practices. Theresa received her Associates Degree in Nursing from the College of Lake County, IL in 1980, her Bachelor’s Degree in Nursing from the University of Milwaukee, WI in 1989, and her Masters of Science in Management and Business in 1993, from National Louis University, IL. She is Board Certified as a Rehabilitation Nurse and as a Board Certified Infection Preventionist. Her APIC SE Chapter 30 Board of Directors two- year appointment commenced 12/6/12.
Anne Ulman, RN, BSN, Lakeview NH Director of Nursing, will be recognized at the October 18, 2012 Annual Convention of the New Hampshire Nurse’s Association. Ms. Ulman will be the recipient of the NH Champion of Nursing Award, a statewide honor given annually to an individual who has had a positive impact on the profession of nursing. The awardee is deemed to have contributed by demonstrating characteristics and practices that support individual nurses and the nursing profession, and is someone who has provided leadership and involvement in the nursing community. Ms. Ulman has been the leader of nursing at Lakeview for many years, joining the organization in early 2003. Under her direction, Lakeview’s depth and breadth of nursing services, including nurse and nurse’s aide fully staffed programs, 24/7 nursing coverage across all residential units, nurse administered medication rounds and team nurse health management, have developed to serve adults and youth with increasing medical complexity. Along with leading a department of over 30 nurses, Ms. Ulman also spearheads facility-wide health and wellness initiatives and education and assists in coordinating Lakeview’s multi-specialty physician services.
Dr. Goza is Director of Lakeview's Youth Services, joining the organization with over a decade of clinical leadership and management experience. Dr. Goza received her doctorate in Clinical Psychology from the APA accredited program at Virginia Polytechnic Institute and State University (Virginia Tech), and completed her APA accredited internship and fellowship at Virginia Commonwealth University's Medical College of Virginia Hospital's Treatment Center for Children.
Bariatrics is the branch of medicine that deals with the treatment of obesity. While many recognize the high rates of obesity and obesity-related health problems in the US population, Lakeview has focused on the risks and challenges of obesity among individuals with medically complexity, brain injury, developmental disabilities and other neurobehavioral disorders. As a leader in the field, Lakeview’s full continuum of specialized, comprehensive bariatric services are delivered through a team-based, person-centered model. Services include dedicated programs for children, adolescents and adults with obesity, from medically complex care in our hospital, to rehabilitation programs, and community integrated services in supported residences or through home health models.
Lakeview NH’s Director of Quality Improvement, Nicholas Cioe, PhD, CRC, recently presented his research on brain Injury treatment outcome at the North American Brain Injury Society (NABIS) conference in Miami. Brain injury has a tremendous effect on the United States. The medical system has a continuum of care available but many of these services are extremely expensive. Despite the effectiveness of residential post-acute brain injury rehabilitation (PABIR) resistance to provide adequate funding remains because of a dearth of randomized controlled trial (RCT) studies demonstrating effectiveness. Some research suggests observational trials are typically more representative of community samples and yield conclusions similar to RCT studies.
In response to an Army Small Business Technology Transfer Program RFP requiring university collaboration, Empirical Technologies, Inc. (ETI - an engineering firm) and the University of Virginia (UVA), have partnered to develop tools to differentiate between mild TBI and PTSD, using neurobiologically based biomarkers. This research project, entitled ‘Non-Invasive Assay to Discriminate between Mild TBI and PTSD’, is a multi-center study under the direction of UVA School of Medicine leader in neuropsychology and concussion, Dr. Jeffrey Barth, at the Defense and Veterans Brain Injury Center (DVBIC) - Charlottesville, and involves former DVBIC-Charlottesville Site Director and current Research Coordinator, Dr. Tina Trudel (Lakeview COO and UVA Asst. Clinical Professor of Psychiatry and Neurobehavioral Sciences). This research is based on the literature on differences between psychological and concussive issues, wherein the measure of visual tracking was evident in the concussion literature (but not for PTSD), as well as the measure of postural stability wherein imbalance was associated with concussion in athletes, but again was not associated with PTSD.
Dr. Tina Trudel, President/COO of Lakeview has been working within the Lakeview programs and field of neurorehabilitation, to increase the use and development of technology. She recently edited a special issue of the North American Brain Injury Society’s (NABIS) publication ‘Brain Injury Professional’, featuring articles on applications of technology in neurorehabilitation. Her Guest Editor column notes:
For the last few years, I have been privileged to serve on the International Scientific Advisory Board of the World Congress of Neurotechnology, which met in Rome in 2010 with representatives from around the world, presenting papers on topics that at times seemed more science fiction than science. The World Congress is now the World Association of Neurotechnology and has evolved as an international on-line forum (www.waneurotech.org) covering the areas of neuroresearch, neuropsychiatry, neuroplasticity, neurooncology and neurosurgery. Myself and others have sought a space for applied technology and neurorehabilitation within this realm of high-tech, heady science. In this arena, technology transfer, venture capital, clinical trials, government approvals and intellectual property rights are as passionately discussed as any scientific findings, and clinical rehabilitation applications share the screen with nanobots carrying designer molecules across the blood brain barrier!